Medtronic earns CE Mark for direct aortic implantation of CoreValve

11/9/2011 | Clinica (subscription required)

European regulators have granted Medtronic approval for the delivery of its CoreValve transcatheter aortic valve implant using a direct aortic approach. The new delivery approach offers an alternative for patients who are not fit to receive the device through femoral artery implantation, said Kathleen Janasz at Medtronic.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI